Hip and Knee Replacement Market Size, Share, Growth, and Industry Analysis, By Type (Hip Replacement,Knee Replacement), By Application (Hospitals,Orthopedic Clinics), Regional Insights and Forecast to 2035

Hip and Knee Replacement Market Overview

The global Hip and Knee Replacement Market size is projected to grow from USD 23987.99 million in 2026 to USD 25506.09 million in 2027, reaching USD 41626.33 million by 2035, expanding at a CAGR of 6.32% during the forecast period.

The global Hip and Knee Replacement Market sees over 2 million combined procedures annually, with hip replacements accounting for approximately 40% and knee revisions for around 60% of surgeries. Average patient age is 65 years, with a gender split of 55% female and 45% male recipients. Implant materials include metal-on-polyethylene (50%), ceramic-on-ceramic (20%), and highly cross-linked polyethylene (30%). Revision surgeries make up 10% of volume, while primary procedures compose 90%. These figures support Hip and Knee Replacement Market Size, Market Insights, and Market Report analysis with precision.

In the USA alone, there were around 900,000 hip and knee replacement procedures in the most recent year, representing approximately 45% of the global total. Hip replacements accounted for 360,000 units (40%) and knee replacements for 540,000 units (60%). Average patient age was 66 years, with female patients at 57%. Revision rates reached 12%, while robotic-assisted procedures comprised 15% of U.S. operations. Implant material usage mirrored global trends: metal-on-polyethylene 52%, ceramic-on-ceramic 18%, cross-linked polyethylene 30%. These U.S. data points are critical for the Hip and Knee Replacement Industry Analysis and Market Insights.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Growth in osteoarthritis prevalence—affecting 25% of adults over 60—boosts procedure volume by 10%.
• Major Market Restraint: Post-operative infection rates of up to 2% restrict adoption in high-risk patient groups.
• Emerging Trends: Robotic-assisted surgeries now represent 15% of total hip and knee replacements.
• Regional Leadership: North America accounts for approximately 45% of global procedure volume, leading regional demand.
• Competitive Landscape: Top two companies hold nearly 35% of implant device share, while the remaining 65% is fragmented.
• Market Segmentation: Hospitals deliver 85% of surgeries; 15% occur in outpatient orthopedic clinics.
• Recent Development: Implant lifespans improved by 20%, now averaging 20 years viability before revision.

Hip and Knee Replacement Market Latest Trends

The Hip and Knee Replacement Market Trends show significant shifts in surgical approaches and implant technology. Robotic-assisted surgeries now represent around 15% of all procedures, offering precision that reduces alignment errors by 30%. Minimally invasive approaches—used in 25% of hip replacements—result in 30% faster patient recovery times. Cross-linked polyethylene implants now comprise 30% of materials, reducing wear rates by 25% compared to conventional polyethylene. Ceramic-on-ceramic implants account for 20%, favored for their low friction and lifespan up to 25 years. Average age of patients is stable at 65 years, but procedures in patients aged 50–60 rose 10%, reflecting growing demand in younger cohorts. Outpatient orthopedic clinics provide 15% of procedures, gaining share due to improved protocols and reduced hospital stays by 35%. This convergence of tech, patient demographics, and care settings shapes Hip and Knee Replacement Market Analysis and defines Future Market Opportunities.

Hip and Knee Replacement Market Dynamics

DRIVER

"Rising prevalence of osteoarthritis among aging populations"

Osteoarthritis affects approximately 25% of adults over 60, driving demand for hip and knee replacements upward by 10%. Aging patient cohorts—65 and older—account for 70% of procedures. Obesity—a factor in 35% of knee candidates—further escalates demand. Expansion of joint replacement in patients aged 50–60 increased 10% in recent years. Improvements in implant lifespan (now averaging 20 years) contribute to rising confidence in replacements. This aging demographic shift and associated chronic joint conditions form a critical engine of Hip and Knee Replacement Market Growth and underpin strategic planning in the Market Forecast.

RESTRAINT

"Post-operative complications and infection rates"

Infection remains a notable concern, affecting approximately 1–2% of joint replacement cases. Use of antibiotic cement reduces infection risk by 30%, but wound complications persist at 3% of surgeries. Re-admission rates due to complications reach 5%, increasing care costs and length of stay. Patient comorbidities—like diabetes present in 20%—magnify complication risk. These clinical barriers limit procedure expansion, especially in outpatient settings. Quality protocols and prophylactic measures are essential to reduce infection and hospital re-admission rates, making this a central friction point in the Hip and Knee Replacement Market Outlook.

OPPORTUNITY

"Technological innovations and outpatient care expansion"

Technologies like robotic assistance now feature in 15% of surgeries, improving alignment precision by 30% and lowering revision rates. Minimally invasive techniques, in 25% of hip cases, enable discharge in <24 hours for 65% of those patients. Cross-linked polyethylene and ceramic materials reduce wear by 25%–30%, extending implant life. Outpatient clinics now handle 15% of total volume, reflecting demand for cost-efficient and convenience care. This tech-driven shift opens Hip and Knee Replacement Market Opportunities in device innovation, outpatient service models, and premium implant materials.

CHALLENGE

"Fragmented supply chain and pricing pressure"

Top two implant manufacturers capture 35% market share; the remaining 65% is served by mid-tier and regional players, challenging economies of scale. Cost pressures from payers and healthcare systems exert downward pricing pressure—especially since hospital reimbursements reduced by 10% on average. Smaller suppliers face difficulties in complying with regulatory standards, with 15% failing audit criteria annually. Supply disruptions in high-performance materials (ceramics) occurred in 12% of facilities. These structural issues hinder uniform quality, limit access, and constrain market expansion, requiring supply chain consolidation and strategic pricing models.

Hip and Knee Replacement Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

The Hip and Knee Replacement Market is segmented by type—Hip Replacement (40%) and Knee Replacement (60%)—and by care setting—Hospitals (85%) and Orthopedic Clinics (15%). This segmentation reflects procedural distribution and informs targeted device development, procurement strategies, and market deployment in the Hip and Knee Replacement Market Report and Market Analysis for B2B decision-makers.

BY TYPE

Hip Replacement: Hip replacements account for 40% of total procedures, with 800,000 units globally. Average patient age is 66 years; 55% are female. Materials: metal-on-polyethylene (50%), ceramic-on-ceramic (20%), cross-linked polyethylene (30%). Robotic assistance is used in 12% of hip surgeries. Minimally invasive hip approaches account for 25%, enabling discharge in <24 hours in 60% of cases. Revision hip surgeries represent 9% of hip volume. These statistics support Hip and Knee Replacement Industry Analysis and guide product focus in the hip device segment.

The Hip Replacement segment is estimated at USD 9,401.24 million in 2025, expected to reach USD 16,069.73 million by 2034, growing at a CAGR of 6.32%, supported by rising osteoarthritis cases and advanced implant technologies.

Top 5 Major Dominant Countries in the Hip Replacement Segment

• United States: Market at USD 3,290.19 million in 2025, projected at USD 5,624.13 million by 2034, CAGR 6.25%, driven by high procedure volumes and strong healthcare infrastructure.
• Germany: Holds USD 1,225.83 million in 2025, expanding to USD 2,107.89 million by 2034, CAGR 6.30%, fueled by advanced orthopedic care and aging demographics.
• Japan: Records USD 1,008.62 million in 2025, projected to USD 1,739.14 million by 2034, CAGR 6.28%, supported by rapid elderly population growth.
• United Kingdom: Accounts for USD 889.71 million in 2025, reaching USD 1,529.02 million by 2034, CAGR 6.35%, backed by NHS orthopedic treatment initiatives.
• France: Generates USD 810.65 million in 2025, estimated at USD 1,389.55 million by 2034, CAGR 6.27%, with strong adoption of minimally invasive surgeries.

Knee Replacement: Knee replacements make up 60% of procedures, totaling around 1.2 million annually. Average patient age is 65 years, with women constituting 57% of cases. Implant material usage includes metal-on-polyethylene (85%), ceramic options (5%), and cross-linked polyethylene (10%). Robotic assistance is used in 18% of knee procedures, with outpatient knee replacements rising to 10%. Revision surgery rate for knee replacements stands at 11%. These details shape Hip and Knee Replacement Market Size and Product Strategy for knee implants.

The Knee Replacement segment is valued at USD 13,160.83 million in 2025, forecasted to achieve USD 23,082.20 million by 2034, advancing at a CAGR of 6.32%, driven by sports injuries and high prevalence of joint disorders.

Top 5 Major Dominant Countries in the Knee Replacement Segment

• United States: Estimated at USD 4,875.26 million in 2025, reaching USD 8,558.87 million by 2034, CAGR 6.34%, supported by large patient pool and cutting-edge knee implant adoption.
• China: Records USD 2,005.32 million in 2025, projected at USD 3,517.69 million by 2034, CAGR 6.35%, driven by expanding healthcare access and rising lifestyle-related disorders.
• India: Achieves USD 1,489.09 million in 2025, set to hit USD 2,610.26 million by 2034, CAGR 6.31%, supported by growing medical tourism and affordability.
• Germany: Generates USD 1,116.38 million in 2025, forecasted at USD 1,955.09 million by 2034, CAGR 6.29%, owing to advanced orthopedic infrastructure.
• Japan: Accounts for USD 924.56 million in 2025, expected at USD 1,617.08 million by 2034, CAGR 6.30%, driven by rising geriatric population.

BY APPLICATION

Hospitals: Hospitals deliver 85% of hip and knee replacements, conducting 1.7 million procedures annually worldwide. Average length of stay is 3 days, with 80% using standard recovery pathways. Robotic-assisted surgeries occur in 15% of hospital cases. Infection prophylaxis protocols reduce rates to 1.5%, though some institutions still experience up to 3%. Revision surgeries represent 10% of hospital volume. Hospitals invest in implant navigation systems in 20% of orthopedic wards. These operational metrics are central to Hip and Knee Replacement Market Forecast for facility-based delivery models.

The Hospitals segment is valued at USD 15,256.38 million in 2025, projected to reach USD 26,489.61 million by 2034, with a CAGR of 6.31%, supported by advanced surgical technologies and higher patient admissions.

Top 5 Major Dominant Countries in the Hospitals Application

• United States: Market at USD 5,432.19 million in 2025, reaching USD 9,434.92 million by 2034, CAGR 6.29%, driven by high hospital-based procedures.
• Germany: Holds USD 1,635.42 million in 2025, projected at USD 2,844.52 million by 2034, CAGR 6.33%, supported by public healthcare dominance.
• China: Accounts for USD 1,425.18 million in 2025, estimated at USD 2,478.41 million by 2034, CAGR 6.32%, driven by improving healthcare investments.
• Japan: Records USD 1,216.59 million in 2025, projected at USD 2,116.24 million by 2034, CAGR 6.34%, with strong hospital infrastructure.
• India: Achieves USD 1,038.27 million in 2025, forecasted at USD 1,807.86 million by 2034, CAGR 6.30%, supported by hospital expansions and rising orthopedic surgeries.

Orthopedic Clinics: Orthopedic outpatient clinics now perform 15% of replacement surgeries, translating to 300,000 cases annually. Average length of stay is <24 hours for 70% of outpatient patients. Infection rates in clinics are around 1%, lower due to streamlined protocols. Robotic-assisted methods account for 10% of clinic procedures. Clinics tend to serve younger patients (average age 63 years) and see a higher outpatient hip volume (20% of hip replacements). These shifts towards ambulatory settings are pivotal for Hip and Knee Replacement Market Opportunities, offering new business models for device suppliers.

The Orthopedic Clinics segment is assessed at USD 7,305.69 million in 2025, expected to hit USD 12,662.32 million by 2034, growing at a CAGR of 6.33%, favored by outpatient surgical adoption and specialized care demand.

Top 5 Major Dominant Countries in the Orthopedic Clinics Application

• United States: Market at USD 2,733.41 million in 2025, projected at USD 4,736.02 million by 2034, CAGR 6.35%, driven by specialized private orthopedic networks.
• China: Accounts for USD 1,201.04 million in 2025, forecasted at USD 2,080.31 million by 2034, CAGR 6.34%, fueled by expansion of orthopedic specialty centers.
• India: Records USD 901.21 million in 2025, estimated at USD 1,561.57 million by 2034, CAGR 6.31%, boosted by outpatient affordability and medical tourism.
• Germany: Holds USD 706.79 million in 2025, projected to USD 1,228.34 million by 2034, CAGR 6.32%, backed by advanced orthopedic clinical systems.
• Japan: Generates USD 629.74 million in 2025, forecasted at USD 1,094.74 million by 2034, CAGR 6.30%, supported by outpatient-focused care.

Hip and Knee Replacement Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

The market is regionalized: North America leads with 45% of procedures, Europe holds 25%, Asia-Pacific accounts for 20%, and Middle East & Africa (MEA) comprises 10%. These distributions guide the Hip and Knee Replacement Market Outlook.

NORTH AMERICA

North America accounts for 45% of global hip and knee replacement volume—approximately 900,000 procedures annually. Hip replacements represent 40% (360,000); knee replacements 60% (540,000). Robotic-assisted surgeries are used in 15%, primarily in hospitals. Outpatient clinic procedures constitute 15% of total. Average patient age is 66 years, with 55% female. Revision rate is 12%. Material usage: metal-on-polyethylene 52%, cross-linked polyethylene 30%, ceramic 18%. Infection rates have reduced to 1.5% via prophylaxis. Average length of stay is 3 days, with 60% discharged within 24 hours in outpatient settings. These metrics underscore North America’s leadership in advanced delivery models, nuanced material adoption, and procedure volume for Hip and Knee Replacement Market Report and Industry Analysis.

The North America market is estimated at USD 9,679.82 million in 2025, projected to reach USD 16,886.41 million by 2034, advancing at a CAGR of 6.31%, driven by high surgical volumes and advanced implants.

North America - Major Dominant Countries in the “Hip and Knee Replacement Market”

• United States: USD 7,165.45 million in 2025, reaching USD 12,502.81 million by 2034, CAGR 6.32%, dominates due to large-scale orthopedic surgeries.
• Canada: USD 1,093.12 million in 2025, estimated at USD 1,908.65 million by 2034, CAGR 6.34%, supported by growing healthcare spending.
• Mexico: USD 824.67 million in 2025, expected at USD 1,438.22 million by 2034, CAGR 6.31%, with rising joint replacement adoption.
• Cuba: USD 323.15 million in 2025, projected at USD 563.79 million by 2034, CAGR 6.29%, driven by increasing orthopedic care.
• Dominican Republic: USD 273.43 million in 2025, reaching USD 473.94 million by 2034, CAGR 6.32%, supported by medical tourism.

EUROPE

Europe contributes 25% of the global procedure volume—around 500,000 surgeries annually. Hip replacements constitute 40% (200,000); knee replacements 60% (300,000). Robotic-assisted procedures are conducted in 10% of cases. Outpatient clinics provide 10% of replacements. Average age is 65 years; 53% are female. Revision rates stand at 11%. Material usage: metal-on-polyethylene 50%, cross-linked polyethylene 30%, ceramic 20%. Infection rates are around 2%. Average hospital stay is 4 days, with 50% discharged within 2 days in enhanced recovery programs. Europe emphasizes minimally invasive and enhanced recovery: 25% of hip replacements follow those pathways. These data shape Europe Market Forecast and Market Insights for orthopedic suppliers and payers.

The Europe market is valued at USD 6,621.08 million in 2025, forecasted at USD 11,554.31 million by 2034, with a CAGR of 6.33%, supported by aging populations and advanced medical technologies.

Europe - Major Dominant Countries in the “Hip and Knee Replacement Market”

• Germany: USD 2,342.21 million in 2025, projected at USD 4,088.53 million by 2034, CAGR 6.34%, leads with advanced orthopedic infrastructure.
• France: USD 1,401.83 million in 2025, reaching USD 2,444.62 million by 2034, CAGR 6.32%, supported by hospital-based procedures.
• United Kingdom: USD 1,266.54 million in 2025, forecasted at USD 2,208.19 million by 2034, CAGR 6.31%, with strong NHS orthopedic programs.
• Italy: USD 963.18 million in 2025, projected at USD 1,678.49 million by 2034, CAGR 6.30%, supported by aging populations.
• Spain: USD 647.32 million in 2025, expected at USD 1,134.48 million by 2034, CAGR 6.28%, driven by orthopedic care expansions.

ASIA-PACIFIC

Asia-Pacific accounts for 20% of global volume—approximately 400,000 annual surgeries. Hip replacements: 40% (160,000); knee replacements: 60% (240,000). Robotic assistance in 8% of cases; outpatient volume 5%. Average age: 64 years, with 52% female. Revision rate: 10%. Material breakdown: metal-on-polyethylene 60%, cross-linked polyethylene 25%, ceramic 15%. Infection rate around 3%. Hospital stay averages 5 days, with 30% discharged within 2 days. Tubal segment shows significant growth: Asia-Pacific demand rose 10% due to aging and elective orthopedic expansion. These metrics inform APAC Market Opportunities and Market Analysis suitable for device suppliers focusing on high-growth markets.

The Asia market is estimated at USD 5,112.48 million in 2025, projected at USD 8,921.23 million by 2034, recording a CAGR of 6.35%, supported by healthcare expansions and large patient base.

Asia - Major Dominant Countries in the “Hip and Knee Replacement Market”

• China: USD 2,204.41 million in 2025, reaching USD 3,847.87 million by 2034, CAGR 6.36%, dominates with affordability-driven demand.
• India: USD 1,390.78 million in 2025, forecasted at USD 2,426.38 million by 2034, CAGR 6.32%, supported by medical tourism.
• Japan: USD 1,174.86 million in 2025, projected at USD 2,048.42 million by 2034, CAGR 6.34%, fueled by rapid elderly population growth.
• South Korea: USD 774.29 million in 2025, expected at USD 1,348.35 million by 2034, CAGR 6.29%, driven by rising healthcare adoption.
• Indonesia: USD 568.14 million in 2025, forecasted at USD 1,009.44 million by 2034, CAGR 6.35%, supported by growing orthopedic care needs.

MIDDLE EAST & AFRICA

MEA represents 10% of global procedure volume—around 200,000 surgeries annually. Hip replacements: 40% (80,000); knee replacements: 60% (120,000). Robotic-assisted surgeries are in 5% of procedures, mostly in private hospitals. Outpatient clinics deliver 3%. Average age: 62 years, with 50% female. Revision rate: 9%. Material usage: metal-on-polyethylene 65%, cross-linked polyethylene 20%, ceramic 15%. Infection rate: 4%. Hospital stay averages 6 days, with 20% discharged by day two under ERAS protocols. Growth driven by increasing elective procedures (+8%) and infrastructure expansion in private sectors. These figures support MEA Market Outlook and Market Opportunities for regional expansion by manufacturers and investors.

The Middle East and Africa market is valued at USD 1,148.69 million in 2025, projected at USD 1,790.01 million by 2034, growing at a CAGR of 5.13%, supported by gradual orthopedic expansion.

Middle East and Africa - Major Dominant Countries in the “Hip and Knee Replacement Market”

• Saudi Arabia: USD 354.17 million in 2025, projected at USD 618.48 million by 2034, CAGR 6.35%, supported by advanced healthcare investments.
• United Arab Emirates: USD 289.67 million in 2025, reaching USD 505.84 million by 2034, CAGR 6.31%, driven by medical tourism.
• South Africa: USD 211.12 million in 2025, expected at USD 368.65 million by 2034, CAGR 6.28%, supported by orthopedic infrastructure.
• Egypt: USD 161.44 million in 2025, forecasted at USD 280.49 million by 2034, CAGR 6.25%, supported by healthcare developments.
• Nigeria: USD 132.29 million in 2025, projected at USD 229.83 million by 2034, CAGR 6.21%, with rising demand for joint surgeries.

List of Top Hip and Knee Replacement Companies

• Smith and Nephew
• Exactech
• B Braun Melsungen
• DePuy Synthes
• Stryker Corporation
• MicroPort
• Corin Group
• Zimmer Biomet Holdings

DePuy Synthes: Estimated to hold approximately 17–20% of global hip and knee implant unit volume, dominant in both hip and knee platforms.

Zimmer Biomet Holdings: Holds around 15–18% of global volume, notable in modular knee systems and enhanced hip implant designs.

Investment Analysis and Opportunities

Investment and opportunity analysis in the Hip and Knee Replacement Market underscores growing demand and technological momentum. Global annual procedures exceed 2 million, with segmentation: hospital volume at 85%, outpatient clinics at 15%; hip procedures 40%, knee 60%. Robotic-assisted surgeries now represent 15% of total, with adoption at 15% in North America, 10% in Europe, 8% in Asia-Pacific, and 5% in MEA. Outpatient replacements are increasing, representing 15% in North America, 10% in Europe, and lower in other regions. Elder patient volume (65+) accounts for 70% of procedures globally. Investments in implant materials like cross-linked polyethylene and ceramics push adoption to 50% combined across all regions. Revision surgeries account for 10–12%, indicating ongoing aftermarket opportunities for revision components. Growth opportunities lie in expanding robotics, outpatient models, and high-performance implants. Investment in R&D for minimally invasive procedures, plus market expansion in Asia-Pacific (at 20% procedure share) and MEA (10% share), opens significant Hip and Knee Replacement Market Opportunities and long-term growth pathways.

New Product Development

New product development in the Hip and Knee Replacement Market has accelerated. In 2023–2025, manufacturers introduced robotic-compatible implants in 15% of hip and 18% of knee procedures. Highly cross-linked polyethylene liners now comprise 30% of liners, achieving wear reduction up to 25%. Ceramic-on-ceramic hip components increased market share to 20%. Modular knee systems with adjustable polyethylene inserts account for 12% of knee implant sales. Minimally invasive hip stems enabling 25% smaller incisions have grown to 20% of teams. Leaner instrumentation—reducing tray counts by 30%—is used in 10% of ORs. Bioactive coating implants encouraging osteointegration make up 5% of new product launches. These innovations enhance Market Trends and provide strategic differentiation in Hip and Knee Replacement Industry Analysis for device manufacturers.

Five Recent Developments

• Robotic platforms now assist 15% of surgeries, up from 10% in 2022.
• Cross-linked polyethylene liners achieved a 25% reduction in wear and represent 30% of new implant volume.
• Ceramic-on-ceramic hip bearings gained to 20% of hip replacements by mid-2024.
• Modular knee systems with customizable inserts now represent 12% of knee implant usage.
• Minimally invasive hip stems are used in 20% of hip procedures as of 2025, reducing incision size by 25%.

Report Coverage of Hip and Knee Replacement Market

The Hip and Knee Replacement Market Research Report provides comprehensive analysis of global procedure volume—exceeding 2 million annually—and regional distribution: North America (45%), Europe (25%), Asia-Pacific (20%), and Middle East & Africa (10%). It details type segmentation: Hip (40%, 800,000 procedures) and Knee (60%, 1.2 million). Care setting is segmented between Hospitals (85%) and Orthopedic Clinics (15%). Technological adoption—robotic assistance (15%), minimally invasive techniques (25% for hip), implant material composition (metal-on-polyethylene 50%, cross-linked polyethylene 30%, ceramic 20%)—is analyzed. Competitive landscape is mapped with DePuy Synthes (17–20% share) and Zimmer Biomet (15–18%), alongside mid-tier players comprising 65% of the market. Innovation coverage includes cross-linked liners, ceramic bearings, modular knees, lean instrumentation, and minimally invasive stems. Revision surgery rates (10–12%), patient demographics (average age 65–66 years, female share 55–57%), and outpatient shift (15% in North America, 10% in Europe) are included. This robust report feeds into Hip and Knee Replacement Market Insights, Forecast, Industry Analysis, and Opportunities for stakeholders navigating product strategy and market expansion.

Hip and Knee Replacement Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 23987.99 Million in 2026
Market Size Value By	USD 41626.33 Million by 2035
Growth Rate	CAGR of 6.32% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Hip Replacement Knee Replacement By Application : Hospitals Orthopedic Clinics
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample